Almonty Industries (ALM) Revenue Jumps 498%. Can Its New Mine Keep Growth Going?

Almonty Industries (ALM) reported a 498% year-over-year revenue increase to C$43.0 million in Q2, driven by rising tungsten prices. The company's adjusted EBITDA swung to a profit of C$17.6 million. ALM raised US$800 million via convertible notes and has C$1.2 billion in cash. Growth depends on its Sangdong mine in South Korea, which began commercial shipments in October, with a long-term supply contract covering over 90% of Phase I production.

Original reporting
Published Nov 9, 2026, 1:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Almonty Industries (ALM) Revenue Jumps 498%. Can Its New Mine Keep Growth Going? — source image
Decision brief

The 30-second read

$ALMBullishMed
01

Why it matters

The Q2 results provide the first quantitative evidence of the mine’s commercial ramp‑up, which could re‑price the stock.

02

Market read

First‑time disclosure of Almonty's strong Q2 performance may trigger buying interest in the stock and related materials sector.

03

What to watch

The long‑term supply contract pricing terms and potential freight cost pressures could limit margin expansion.

Relevance 6/10Novelty 8/10Timing: post-market today

Background

Almonty Industries operates the Sangdong tungsten mine in South Korea and recently secured a long‑term offtake contract covering >90% of Phase I production.

Company-level read

Ticker impact

$ALMBullishHigh confidence
Context

Almonty Industries reported Q2 revenue up 498% YoY to C$43.0M and a swing to positive adjusted EBITDA.

Expected impact

likely upward pressure as investors price in the revenue surge and EBITDA improvement

Evidence & confidence

The disclosed numbers are the first public report of Almonty's Q2 results, showing a dramatic revenue increase and a move to positive EBITDA, which typically drives buying interest.

Market effects

Highlights strength in the tungsten mining segment and may lift other materials stocks.

Boosts sentiment for North American mining companies with exposure to Asian demand.

Shows demand for critical minerals amid data‑center construction, relevant to global supply‑chain investors.

Counterpoint

The rapid revenue jump may be unsustainable if tungsten prices soften or operating costs rise.

Key entities

  • Almonty Industries

    US‑listed tungsten mining company (NASDAQ:ALM).

  • Sangdong Mine

    Almonty's primary tungsten mine in South Korea.

Related articles

$ALMMed

Defense Stockpile Orders Send Explorers Back to Old Tungsten Camps

The U.S. Defense Logistics Agency awarded a $2B contract for tungsten supplies, with a $450M investment from the Department of War. GoldHaven Resources (CSE: GOH) completed drilling at its Kuhn tungsten-skarn target, intersecting skarn mineralization in two locations. Almonty Industries (NASDAQ: ALM) began commercial operations at its Sangdong plant, with 90% of Phase I production contracted. Guardian Metal (NYSE: GMTL) reported drilling results from its Tempiute project.

$ELMTMed

Technology Metals Report (10.04.2026): A Summit Without a Rare Earth Deal Leaves the West Buying Its Way to Supply

The U.S. and China failed to reach a rare earth supply deal during Xi Jinping's visit, leaving the West to secure supplies. Rare earth exports from China to the U.S. declined, with prices showing mixed trends. Elmet Group and Almonty Industries are expanding tungsten production. Glencore will partner with the U.S. strategic minerals reserve. Eramet plans to expand lithium production in Argentina. Processing capacity is also increasing, with Korea Zinc planning a U.S. smelter.

$ALMMed

Almirall, S.A.: Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026

Almirall, S.A. (ALM) presented new clinical data at EADV 2026, showcasing advances in dermatology treatments. Key findings include sustained improvements in atopic dermatitis with lebrikizumab and benefits in psoriasis with tildrakizumab. The company also highlighted its commitment to medical dermatology through sponsorship and awareness campaigns.

$ALMMed

Almonty Industries ALM Stock Rallies On Tungsten Breakout

Almonty Industries (NASDAQ: ALM) stock rose 11.09% on positive tungsten market news and project progress. The company reported $42.99M in quarterly revenue, $1.22B in cash, and a share buyback plan. ALM secured inspection certificates for its Sangdong project in South Korea and expanded operations in Rwanda, positioning itself as a key tungsten supplier outside China.